Mimix™ Colorectal Cancer Panel Negative Control, ctDNA Reference Standard
The Colorectal Cancer ctDNA Panel reference standard negative control is well characterized, cell line-derived control material manufactured under ISO 9001:2015 and ISO 13485:2016 that is tested negative for 10 variants across 10 genes clinically relevant to colorectal cancers.
Clearance sale: Discounted pricing on selected cfDNA inventory. Limited availability.*
*This pricing promotion is only valid on selected products and while stocks last. Not valid in Italy and China. The promotion cannot be combined with any other promotions, discounts, or offers. Conditions of the promotions may change, and Revvity may void, change, cancel, suspend, or amend this promotion without notice.
Product name change
As part of the continuous evolution of our portfolio, we have changed the name of our range to Mimix™ reference standards to better reflect the patient-like performance they provide.
While our product range has a new name, everything you rely on remains the same:
- Identical formulation and performance
- Same part numbers and SKUs
- Existing protocols and procedures
- Same technical specifications
- Quality and reliability you trust
No action is required from you. Future orders, product labels, documentation, and communications will reference the new product name.